TARS Past Earnings image   This TARS past earnings page last updated 11/11/2022
TARS Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/9/2022-0.840
Q2 20228/11/2022-0.240
Q1 20225/10/2022-0.980
Q4 20213/14/2022-0.720
Q3 202111/9/2021-0.760
Q2 20218/4/20210.290
Q1 20215/11/20210.470
Q4 20203/31/2021-1.850
Q3 202011/25/2020-3.710
TARS Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/9/2022NA
Q2 20228/11/20220.02B
Q1 20225/10/20220.00B
Q4 20213/14/20220.00B
Q3 202111/9/20210.00B
Q2 20218/4/20210.02B
Q1 20215/11/20210.03B
Q4 20203/31/2021NA
Q3 202011/25/2020NA
Quotes delayed 20 minutes

Email EnvelopeFree TARS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Tarsus Pharmaceuticals (TARS) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

TBIO Past Earnings
TCDA Past Earnings
TCMD Past Earnings
TCON Past Earnings
TCRR Past Earnings
TCRT Past Earnings
TCRX Past Earnings
TDOC Past Earnings
TECH Past Earnings
TELA Past Earnings

TARS Past Earnings Q&A

What was the best and worst TARS past earnings results?
For Tarsus Pharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest TARS past earnings result in our data set was 0.470/share posted in Q1 2021, while the lowest was in Q3 2020 when TARS posted -3.710/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2021 when TARS reported 0.03B in revenue, while the quarter with the lowest revenue in our data set was Q3 2022 at NA of revenue.

  Suggested answer: There are 9 TARS past earnings results in our data set.

On this page we presented the TARS past earnings date information for Tarsus Pharmaceuticals. Reviewing that TARS Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2021, when TARS posted gaap of 0.470/share. Meanwhile the lowest TARS past earnings result was in Q3 2020, when TARS posted gaap of -3.710/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2021 when TARS reported 0.03B in revenue, while the smallest revenue quarter was Q3 2022 when TARS reported NA in revenue.

Any self directed investor doing their due diligence on TARS or any other given stock can benefit from researching all of the Tarsus Pharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Tarsus Pharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for TARS. Thanks for visiting, and the next time you need to research TARS past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: AMAT YTD Return, LRMR Average Annual Return, Darden Restaurants MACD.


TARS Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.